Wyeth Pharmaceuticals reports positive results from two phase III clinical studies of Pristiq Dec. 18, 2007
Ceregene reports positive long-term follow-up results from phase I clinical trial of CERE-120 Dec. 17, 2007
Botulinum toxin type B effective in sialorrhea in amyotrophic lateral sclerosis patients Dec. 17, 2007
FDA deems Neurocrine's NDA for indiplon approvable pending additional safety and efficacy data Dec. 14, 2007
RSS